Compound ID | 2475
Class: RNA polymerase inhibitor
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Active against Chlamydia sp., Corynebacterium mediolanum, Mycobacterium bovis, Staphylococcus aureus, and Wolbachia sp. |
| Description: | Natural product from Corallococcus (=Myxococcus=Chondrococcus) coralloides strain Cc127 (DSM 2550) |
| Institute where first reported: | Univ. of Leeds, UK; Institute for Pharmaceutical Biology, University of Bonn, Germany |
| Year first mentioned: | 1985 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Selects for resistance (7.2E-8) and has minimal activity, it was suggested this may be a potential scaffold for investigation and optimisation. |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/135570663 |
| Guide to Pharmacology: | Corallopyronin A |
| Citations: |
|
| Patent: | EP2704708B1 |